About Pharos iBio
The Best Target & The Best Chemical
Pharos iBio is a new drug development company that develops treatments for rare and refractory diseases using a new drug development platform based on big data and AI technology.
- Based on big data analysis and artificial intelligence (AI) technology using BT&IT technology, we developed and built Chemiverse Platform, a new drug development platform, to introduce innovative new drug candidates.
- Development of new drugs specializing in rare and refractory diseases treatment and expansion of pipelines based on proprietary technology and innovative platform
- Expanding human and material resources and pursuing challenges beyond the limits through open innovation strategies
- Pharos iBio Information
Pharos iBio Co., Ltd.
Apr 19, 2016
Big data and AI-based new drug development system Development of new drug specializing in treatment of rare and refractory diseases
1407&1408, 38, Heungan-daero 427beon-gil, Dongan-gu, Anyang-si, Gyeonggi-do, Republic of Korea
25 workers (R&D manpower : 20, 80%) As at end of March, 2022
Yonsei University College of medicine SBSI
Graduate School of New Drug Discovery and Development, CNU
Seoul National University
Kangwon National University
A number of other basic R&D specialized institutions